Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Management
Sign Up to like & getrecommendations! Published in 2022 at "Cornea"
DOI: 10.1097/ico.0000000000003162
Abstract: Supplemental Digital Content is Available in the Text. Abstract: Emerging monoclonal antibody therapies are assuming greater importance in the management of severe and refractory forms of immunity-driven and oncological disorders. However, some have been found… read more here.
Keywords: adverse ocular; belantamab mafodotin; etiology; management ... See more keywords
Adverse Ocular Effects of Systemic Medications
Sign Up to like & getrecommendations! Published in 2023 at "Life"
DOI: 10.3390/life13030660
Abstract: While ocular complications of systemic medications are uncommon, it is important to recognize that vision-threatening toxicities can occur. This review details the vision-threatening adverse effects of a select group of commonly prescribed systemic medications and… read more here.
Keywords: ocular effects; adverse ocular; effects systemic; systemic medications ... See more keywords